Quality of life, clinical effectiveness, and satisfaction in patients with beta thalassemia major and sickle cell anemia receiving deferasirox chelation therapy.

Senol, Sefika Pinar; Tiftik, Eyup Naci; Unal, Selma; Akdeniz, Aydan; Tasdelen, Bahar; Tunctan, Bahar

Senol, Sefika Pinar; Tiftik, Eyup Naci; Unal, Selma; Akdeniz, Aydan; Tasdelen, Bahar; Tunctan, Bahar.

Afiliação

Senol SP; Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey.
Tiftik EN; Department of Internal Medicine, Faculty of Medicine, Mersin University, Mersin, Turkey.
Unal S; Department of Pediatric Hematology, Faculty of Medicine, Mersin University, Mersin, Turkey.
Akdeniz A; Department of Internal Medicine, Faculty of Medicine, Mersin University, Mersin, Turkey.
Tasdelen B; Department of Biostatistics, Faculty of Medicine, Mersin University, Mersin, Turkey.
Tunctan B; Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey.

J Basic Clin Pharm ; 7(2): 49-59, 2016 Mar.

Article em En | MEDLINE | ID: mdl-27057126

Palavras-chave

Beta thalassemia major; compliance; deferasirox chelation therapy; sickle cell anemia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Aspecto: Patient_preference Idioma: En Revista: J Basic Clin Pharm Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google